Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HUT vs MRNA✓SelectedUSD · MRNAHUT vs MRNA performance historyLatest closeAs of+5.97%11/18
Stock and ETF performance explorer

HUT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-40.6%
MRNA return
+293.7%
Excess return
-334.3%
Maximum drawdown
-65.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+6.0%-4.8%+10.8%+6.1%
7D-6.3%-20.9%+14.5%-5.8%
30D-16.1%-13.3%-2.8%-15.8%
3M-29.2%+212.6%-241.8%-32.0%
6M-40.6%+309.0%-349.6%-51.5%
All-40.6%+293.7%-334.3%-51.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling